mogroside VI
General Information
| Mainterm | mogroside VI |
| CAS Reg.No.(or other ID) | 89590-98-7 |
| Regnum |
From www.fda.gov
Computed Descriptors
Download SDF| 2D Structure | |
| CID | 71307458 |
| IUPAC Name | (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6R)-6-[[(3S,8R,9R,10R,11R,13R,14S,17R)-17-[(2R,5R)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-6-(hydroxymethyl)oxane-3,4,5-triol |
| InChI | InChI=1S/C66H112O34/c1-24(9-13-37(63(4,5)88)98-61-55(100-59-53(87)47(81)41(75)31(21-70)94-59)49(83)43(77)33(96-61)23-90-57-51(85)45(79)39(73)29(19-68)92-57)25-15-16-64(6)34-12-10-26-27(66(34,8)35(71)17-65(25,64)7)11-14-36(62(26,2)3)97-60-54(99-58-52(86)46(80)40(74)30(20-69)93-58)48(82)42(76)32(95-60)22-89-56-50(84)44(78)38(72)28(18-67)91-56/h10,24-25,27-61,67-88H,9,11-23H2,1-8H3/t24-,25-,27-,28-,29-,30-,31-,32-,33-,34-,35-,36+,37-,38-,39-,40-,41-,42-,43-,44+,45+,46+,47+,48+,49+,50-,51-,52-,53-,54-,55-,56-,57-,58+,59+,60+,61+,64+,65-,66+/m1/s1 |
| InChI Key | LTDANPHZAHSOBN-QYTMKXBISA-N |
| Canonical SMILES | CC(CCC(C(C)(C)O)OC1C(C(C(C(O1)COC2C(C(C(C(O2)CO)O)O)O)O)O)OC3C(C(C(C(O3)CO)O)O)O)C4CCC5(C4(CC(C6(C5CC=C7C6CCC(C7(C)C)OC8C(C(C(C(O8)COC9C(C(C(C(O9)CO)O)O)O)O)O)OC1C(C(C(C(O1)CO)O)O)O)C)O)C)C |
| Molecular Formula | C66H112O34 |
From Pubchem
Computed Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 1449.588 |
| Hydrogen Bond Donor Count | 22 |
| Hydrogen Bond Acceptor Count | 34 |
| Rotatable Bond Count | 23 |
| Complexity | 2690.0 |
| CACTVS Substructure Key Fingerprint | A A A D c f B 8 P g A A A A A A A A A A A A A A A A A A A Y A A A A A 0 a J E i Q A A A A G C A A A A A G g A A C A A A D 1 S w g A M C C A A A B g C A A i B C A A A A A A A g A A A A C A A A A A g R E A I A A Q A i Q A A F w A A P A A P A 4 P w P g A A A A A A A A A D A A A Y A A D A A A Q A A C A A A A A = = |
| Topological Polar Surface Area | 556.0 |
| Monoisotopic Mass | 1448.704 |
| Exact Mass | 1448.704 |
| XLogP3 | None |
| XLogP3-AA | -5.3 |
| Compound Is Canonicalized | True |
| Formal Charge | 0 |
| Heavy Atom Count | 100 |
| Defined Atom Stereocenter Count | 40 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.7235 |
| Human Intestinal Absorption | HIA+ | 0.6693 |
| Caco-2 Permeability | Caco2- | 0.9017 |
| P-glycoprotein Substrate | Substrate | 0.8758 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6952 |
| Non-inhibitor | 0.8148 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8183 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.7664 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8734 |
| CYP450 2D6 Substrate | Non-substrate | 0.8747 |
| CYP450 3A4 Substrate | Substrate | 0.7176 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9112 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8767 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9371 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9161 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9485 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9421 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9347 |
| Inhibitor | 0.5678 | |
| AMES Toxicity | Non AMES toxic | 0.9393 |
| Carcinogens | Non-carcinogens | 0.9608 |
| Fish Toxicity | High FHMT | 0.9578 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9973 |
| Honey Bee Toxicity | High HBT | 0.8442 |
| Biodegradation | Not ready biodegradable | 0.9697 |
| Acute Oral Toxicity | III | 0.5598 |
| Carcinogenicity (Three-class) | Non-required | 0.6022 |
From admetSAR
ADMET Predicted Profile --- Regression
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -4.5594 | LogS |
| Caco-2 Permeability | -0.4849 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 3.6718 | LD50, mol/kg |
| Fish Toxicity | 1.2485 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.9058 | pIGC50, ug/L |
From admetSAR